These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Progression to development of lymphoma in the thymus of AKR mice treated neonatally with SL 3-3 virus. Hays EF, Bristol GC, Lugo JP, Wang XF. Exp Hematol; 1989 Dec; 17(11):1116-21. PubMed ID: 2511036 [Abstract] [Full Text] [Related]
10. Phenotypic characterization of thymic prelymphoma cells of B10 mice treated with split-dose irradiation. Muto M, Kubo E, Kamisaku H, Sado T. J Immunol; 1990 Feb 01; 144(3):849-53. PubMed ID: 2104913 [Abstract] [Full Text] [Related]
15. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells. Green WR. J Immunol; 1983 Dec 15; 131(6):3078-84. PubMed ID: 6605998 [Abstract] [Full Text] [Related]
17. The effects of passive antiviral immunotherapy in AKR mice: I. The susceptibility of AKR mice to spontaneous and induced T cell lymphomagenesis. Haran-Ghera N, Peled A, Wu L, Shortman K, Brightman BK, Fan H. Leukemia; 1995 Jul 15; 9(7):1199-206. PubMed ID: 7630195 [Abstract] [Full Text] [Related]
18. Characteristics of potential lymphoma-inducing cells in mice sensitive or resistant to lymphomagenesis by radiation leukemia virus variants. Gokhman I, Peled A, Haran-Ghera N. Cancer Res; 1990 May 01; 50(9):2554-61. PubMed ID: 2158393 [Abstract] [Full Text] [Related]